AM211 is primarily utilized in the field of medical research, particularly in the study of cannabinoid receptors. It acts as a selective antagonist for the CB1 receptor, making it a valuable tool for investigating the physiological and pathological roles of these receptors in the body. Researchers use AM211 to better understand conditions such as chronic pain, inflammation, and neurodegenerative diseases. Its application extends to preclinical studies aimed at developing new therapeutic strategies targeting the endocannabinoid system. Additionally, AM211 is employed in pharmacological assays to assess the efficacy and safety of potential drugs interacting with cannabinoid receptors.